292 related articles for article (PubMed ID: 28468588)
21. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
22. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
[TBL] [Abstract][Full Text] [Related]
23. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-1285-5p influences the proliferation and metastasis of non-small-cell lung carcinoma cells via downregulating CDH1 and Smad4.
Zhou S; Zhang Z; Zheng P; Zhao W; Han N
Tumour Biol; 2017 Jun; 39(6):1010428317705513. PubMed ID: 28631567
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
27. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
Xu E; Zhao J; Ma J; Wang C; Zhang C; Jiang H; Cheng J; Gao R; Zhou X
Oncol Rep; 2016 Jan; 35(1):275-83. PubMed ID: 26549292
[TBL] [Abstract][Full Text] [Related]
28. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
29. miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1.
Hou XW; Sun X; Yu Y; Zhao HM; Yang ZJ; Wang X; Cao XC
Neoplasma; 2017; 64(4):526-534. PubMed ID: 28485158
[TBL] [Abstract][Full Text] [Related]
30. miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.
Wu Q; Luo G; Yang Z; Zhu F; An Y; Shi Y; Fan D
FEBS Lett; 2014 Jun; 588(12):2055-62. PubMed ID: 24801601
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer.
Huang T; She K; Peng G; Wang W; Huang J; Li J; Wang Z; He J
Int J Oncol; 2016 Oct; 49(4):1437-44. PubMed ID: 27498924
[TBL] [Abstract][Full Text] [Related]
32. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
33. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
34. CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p.
Li J; Tang Z; Wang H; Wu W; Zhou F; Ke H; Lu W; Zhang S; Zhang Y; Yang S; Ni S; Huang J
Biomed Pharmacother; 2018 Jan; 97():1182-1188. PubMed ID: 29136957
[TBL] [Abstract][Full Text] [Related]
35. miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1.
Dang W; Qin Z; Fan S; Wen Q; Lu Y; Wang J; Zhang X; Wei L; He W; Ye Q; Yan Q; Li G; Ma J
Oncotarget; 2016 May; 7(22):32421-32. PubMed ID: 27107415
[TBL] [Abstract][Full Text] [Related]
36. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway.
Bai X; Shao J; Zhou S; Zhao Z; Li F; Xiang R; Zhao AZ; Pan J
J Exp Clin Cancer Res; 2019 Nov; 38(1):479. PubMed ID: 31783879
[TBL] [Abstract][Full Text] [Related]
38. MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis.
Song Q; Liu B; Li X; Zhang Q; Cao L; Xu M; Meng Z; Wu X; Xu K
Biochem Biophys Res Commun; 2018 Jun; 501(2):494-500. PubMed ID: 29746867
[TBL] [Abstract][Full Text] [Related]
39. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.
Zhao X; Zhang W; Ji W
Biochem Biophys Res Commun; 2018 Jun; 501(2):584-592. PubMed ID: 29753737
[TBL] [Abstract][Full Text] [Related]
40. Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.
He S; Li Z; Yu Y; Zeng Q; Cheng Y; Ji W; Xia W; Lu S
Exp Cell Res; 2019 Jun; 379(2):203-213. PubMed ID: 30978341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
